Sept. 12, 2024: What’s next for MDMA after FDA rejection? Interpreting a lost Euripidean find

Researchers hoped the FDA would approve the drug commonly known as "ecstasy" to help treat PTSD. But now that the FDA has rejected it in a surprise decision, what's next for the psychedelic? Then, two CU Boulder scholars interpret what they believe to be previously unknown fragments of two lost tragedies by the Greek playwright Euripides. And, using mammograms to increase awareness of dense breast tissue.